A Bioclinical Pattern for the Early Diagnosis of Cardioembolic Stroke
Table 2
Biomarker distribution in 114 patients according to TOAST classification.
Cardioembolic
Large-artery atherosclerosis
Small-vessel occlusion (lacune)
Undetermined aetiology
value*
NT-proBNP (pg/mL)
254 (149–327)
137 (79–176)
86 (40–183)
117 (75–188)
0.0001
Albumin (g/mL)
3.9 (3.8–4.1)
4.1 (3.8–4.2)
4.0 (3.9–4.4)
3.9 (3.7–4.1)
0.04
Globulins (g/mL)
3.2 (2.9–3.4)
2.9 (2.8–3.3)
3.0 (2.6–3.4)
3.0 (2.7–3.3)
0.45
Globulin/albumin
0.79 (0.72–0.88)
0.74 (0.70–0.79)
0.76 (0.62–0.83)
0.77 (0.69–0.85)
0.13
CRP (g/mL)
0.48 (0.23–0.98)
0.37 (0.14–0.62)
0.43 (0.14–1.48)
0.34 (0.15–1.65)
0.44
DD (g/mL)**
406 (282–845)
408 (239–724)
304 (185–435)
308 (196–588)
0.17
All values are median (first and third quartile).
*From chi-square (categorical) or Kruskal-Wallis test (continuous variables).
**Determinations made on 101 (31, 23, 17, and 30) US echocardiographic examinations.
